Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Rob Jones

- PMLiVE

Novo Nordisk and Dewpoint partner on insulin resistance drug candidates

Insulin resistance affects around 15.5% to 46.5% of the world’s population

- PMLiVE

The increasing value of rare disease trials

By Emily Wigginton

- PMLiVE

Wrapping up EAU with a Look at Medscape’s Urology Impact

The Medscape Education Global team has returned from EAU in Milan, Italy, having presented an educational symposium and a networking event with Urology faculty and supporters.The educational symposium, Harnessing the...

Medscape Education

- PMLiVE

MHRA to introduce new UK clinical trials framework

The changes will aim to make it easier to gain approval and to run clinical trials in the UK

- PMLiVE

Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children

Dupixent is now the first and only targeted medicine in the EU for this patient population

- PMLiVE

Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test

If approved, the test could streamline the journey to diagnosis for more patients

- PMLiVE

Inizio appoints Stefanie Christmas as global head of DE&I

Christmas joins from Vynamic, where she founded the firm’s DE&I efforts in 2016

- PMLiVE

Rare diseases: not so rare after all

The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment

- PMLiVE

Sanofi/Regeneron’s Dupixent shows promise in atopic hand and foot dermatitis

Atopic dermatitis affects over 26 million people in the US alone

- PMLiVE

Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis

Plaque psoriasis accounts for around 80-90% of the 125 million psoriasis cases worldwide

- PMLiVE

UCB’s bimekizumab shows continued improvement in hidradenitis suppurativa patients

There is currently only one approved biologic treatment for the inflammatory skin disease

- PMLiVE

The Considered appoints Bam Zahraie as chief experience officer

Zahraie was previously global innovation lead and associate managing director at Havas Health & You

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links